Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Srph031080 Human Insulin Soluble Insulin 30 Percent And Insulin Isophane 70 Percent 40 Iu/Ml 10 Ml Injection.
Srph031212 Insulin Aspart 30 Percent And Protamine Insulin Aspart 70 Percent Suspension 100 I.U / Ml, 3 Ml Cartridge
Unit:Cart.
Srph031229 Monocomponent Biosynthetic R Dna Insulin Solution For Injection In 3 Ml Cartridge For Subcutaneous Use 70 Percent Insulin Degludec/30 Percent Insulin Aspart Penfill 100 Units Per Ml.
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106382676 |
|
Reference Number |
97245526C |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | |
| Place | Chennai |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/072024/106382676/viewNitPdf_4613062.pdf |
| Start Date | June 20, 2024 19:54 |
| End Date |
Expired
01/07/2024
Expired 704 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSrph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSrph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSupply of srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSupply of srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart.
For complete deion and other details, please refer to tender
Read more(ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec 30 percent insulin aspart - 100 iu/ml - 3ml
For complete deion and other details, please refer to tender
Read more( ph.no. 31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec 30 percent insulin aspart - 100 iu/ml - 3ml penfil
For complete deion and other details, please refer to tender
Read moreInj. insulin aspart (biosynthetic r-dna origine) penfill 100 iu/ml cartridge
For complete deion and other details, please refer to tender
Read more30 percent soluble insulin aspart 70 percent insulin aspart protamine - 100 iu /ml - 3 ml penfills
For complete deion and other details, please refer to tender
Read moreHuman r-dna insulin mix 30 percent soluble, 70 percent isophane 100 i.u/ml, 10 ml vial
For complete deion and other details, please refer to tender
Read moreof your Industry type